oral glp-1 agonist for type 2 diabetes In the phase 3 ACHIEVE-1 trial, published in June 2025, the small-molecule receptor orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with A Review on Semaglutide: An

Effect of oral intake of choline-stabilized orthosilicic acid on hair tensile strength and morphology in women with fine hair

Afamelanotide is approved in Europe and the US for a severe light-sensitivity condition called erythropoietic protoporphyria patients in trials were able to spend substantially more time in sunlight without pain

The association of each apolipoprotein with plaques is summarized in Table 1, and section of Imaging correlates provided details of major and large clinical studies on the association of each apolipoprotein with atherosclerotic coronary plaques

The Contribution of Non-Food-Based Exposure to Gluten on the Management of Coeliac Disease